GeneDx Holdings Corp (WGS)

Currency in USD
103.51
+11.73(+12.78%)
Closed·
After Hours
103.510.00(0.00%)
·

WGS Financial Summary

Key Ratios

P/E Ratio1,752.06
Price/Book8.76
Debt / Equity41.27%
Return on Equity0.6%
Dividend Yield0.00%
EBITDA-408.00K
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 104.61
(+1.06% Upside)

Earnings

Latest Release
Jul 29, 2025
EPS / Forecast
0.50 / 0.12
Revenue / Forecast
102.70M / 85.45M
EPS Revisions
Last 90 days

FAQ

What were GeneDx Holdings's earnings for the latest quarter?

The GeneDx Holdings EPS (TTM) is 0.05. GeneDx Holdings reported sales of 102.69, net income of 10.81, and EPS of 0.50 for the latest quarter.

What was GeneDx Holdings's net income for the latest quarter?

GeneDx Holdings's net income for the latest quarter was 10.81.

How did GeneDx Holdings's performance compare year-over-year in the latest quarter?

The company's revenue moved from 87.12 in the previous quarter to 102.69 in the latest quarter, and net income moved from -6.53 to 10.81 compared to the previous quarter.

What is GeneDx Holdings's net profit margin on a TTM basis?

GeneDx Holdings's trailing twelve months (TTM) net profit margin is -17.12%.

How does GeneDx Holdings's debt to equity ratio compare to industry standards?

GeneDx Holdings's total debt-to-equity ratio is 41.27%.

What is GeneDx Holdings's return on investment on a TTM basis?

GeneDx Holdings's trailing twelve months (TTM) return on investment (ROI) is 0.60%.

Did GeneDx Holdings gain or lose cash last quarter?

In the latest quarter, GeneDx Holdings's net change in cash was -25.58 million.

What were GeneDx Holdings's total assets and liabilities in the latest quarter?

As of the latest quarter, GeneDx Holdings reported total assets of 463.86 million and total liabilities of 71.41 million.

How has GeneDx Holdings's total revenue grown this year?

GeneDx Holdings's total revenue was 87.12 in the previous quarter and 102.69 in the latest quarter.

What is GeneDx Holdings's gross margin on a TTM basis?

GeneDx Holdings's trailing twelve months (TTM) gross margin is 65.27%.

What was GeneDx Holdings's revenue per share for the latest quarter?

GeneDx Holdings's revenue per share for the latest quarter was 72.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.